RxDoctor Payments Data

Christopher Morrissey, DO

Surgery · Winfield, KSNPI 1164606919

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $65,400 of the $86,567 with a category attached, or 75.5%. Smith+Nephew accounts for 97.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $24,963 and has fallen 78.4% since, to $5,390 in 2025. Among surgery clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$86,567in general payments, 2019–2025

Across 253 payments — averaging $342.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$84K
  • Heron Therapeutics, Inc.$2K
  • AbbVie$127
  • Organogenesis Inc.$119
  • Biowound Solutions, Inc.$97
  • Osiris Therapeutics Inc.$52
  • plus $291 from 11 others

What the payments were for

  • Consulting fees$2,5003%
  • Speaking & faculty fees$65,40076%
  • Travel & lodging$14,61117%
  • Food & beverage$4,0555%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$86,567 in reported general payments places this provider in the 95th percentile of 271 surgery providers in Kansas.

See all surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$8,548
Medicare patients
40
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole125$766
Sucralfate11$360
Pantoprazole Sodium35$241
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$153

Paid to pharmacies, not to this prescriber.

Other surgery in Winfield

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →